377 related articles for article (PubMed ID: 31706167)
21. The association between dietary total antioxidant capacity and NMO-IgG seropositivity in patients with neuromyelitis optica spectrum disorder.
Rezaeimanesh N; Jahromi SR; Sahraian MA; Rafiee P; Moghadasi AN
Clin Neurol Neurosurg; 2021 Oct; 209():106903. PubMed ID: 34461362
[TBL] [Abstract][Full Text] [Related]
22. [Retrospective study of clinical features of neuromyelitis optica spectrum disease with connective tissue disease].
Zhang Y; Fei Y; Niu J; Ren H; Zhao J; Wang Q; Xu Y
Zhonghua Yi Xue Za Zhi; 2014 Oct; 94(39):3056-61. PubMed ID: 25549677
[TBL] [Abstract][Full Text] [Related]
23. Neuromyelitis optica spectrum disorder (NMOSD): A new concept.
de Sèze J; Kremer L; Collongues N
Rev Neurol (Paris); 2016; 172(4-5):256-62. PubMed ID: 27157418
[TBL] [Abstract][Full Text] [Related]
24. Serum Creatine Kinase in Patients with Neuromyelitis Optica Spectrum Disorder.
Shouman K; Prieto PG; Stino AM; Lisak RP
J Neuroimmunol; 2019 May; 330():87-89. PubMed ID: 30851543
[TBL] [Abstract][Full Text] [Related]
25. Neuromyelitis optica: association with paroxysmal painful tonic spasms.
Carnero Contentti E; Leguizamón F; Hryb JP; Celso J; Pace JL; Ferrari J; Knorre E; Perassolo MB
Neurologia; 2016 Oct; 31(8):511-5. PubMed ID: 25655945
[TBL] [Abstract][Full Text] [Related]
26. The Clinical Characteristics of Primary Sjogren's Syndrome With Neuromyelitis Optica Spectrum Disorder in China: A STROBE-Compliant Article.
Qiao L; Wang Q; Fei Y; Zhang W; Xu Y; Zhang Y; Zhao Y; Zeng X; Zhang F
Medicine (Baltimore); 2015 Jul; 94(28):e1145. PubMed ID: 26181553
[TBL] [Abstract][Full Text] [Related]
27. Utility of aquaporin-4 antibody assay in patients with neuromyelitis optica spectrum disorders.
Kim SM; Waters P; Woodhall M; Kim JY; Kim JE; Yang JW; Kim JS; Sung JJ; Park KS; Lee KW
Mult Scler; 2013 Jul; 19(8):1060-7. PubMed ID: 23329699
[TBL] [Abstract][Full Text] [Related]
28. Clinical features of neuromyelitis optica in children: US Network of Pediatric MS Centers report.
Chitnis T; Ness J; Krupp L; Waubant E; Hunt T; Olsen CS; Rodriguez M; Lotze T; Gorman M; Benson L; Belman A; Weinstock-Guttman B; Aaen G; Graves J; Patterson M; Rose JW; Casper TC
Neurology; 2016 Jan; 86(3):245-52. PubMed ID: 26683648
[TBL] [Abstract][Full Text] [Related]
29. Neuromyelitis optica spectrum disorder: Pathogenesis, treatment, and experimental models.
Wu Y; Zhong L; Geng J
Mult Scler Relat Disord; 2019 Jan; 27():412-418. PubMed ID: 30530071
[TBL] [Abstract][Full Text] [Related]
30. Seronegative neuromyelitis optica spectrum disorder patients diagnosed using new diagnostic criteria.
Uzawa A; Mori M; Uchida T; Masuda H; Ohtani R; Kuwabara S
Mult Scler; 2016 Sep; 22(10):1371-5. PubMed ID: 26552730
[TBL] [Abstract][Full Text] [Related]
31. Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype.
Kitley J; Woodhall M; Waters P; Leite MI; Devenney E; Craig J; Palace J; Vincent A
Neurology; 2012 Sep; 79(12):1273-7. PubMed ID: 22914827
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of the 2015 diagnostic criteria for neuromyelitis optica spectrum disorder.
Hyun JW; Jeong IH; Joung A; Kim SH; Kim HJ
Neurology; 2016 May; 86(19):1772-9. PubMed ID: 27164713
[TBL] [Abstract][Full Text] [Related]
33. Treatment of neuromyelitis optica/neuromyelitis optica spectrum disorders with methotrexate.
Ramanathan RS; Malhotra K; Scott T
BMC Neurol; 2014 Mar; 14():51. PubMed ID: 24628894
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of rituximab in the treatment of neuromyelitis optica spectrum disorders: An update systematic review and meta -analysis.
Wang Y; Chang H; Zhang X; Yin L
Mult Scler Relat Disord; 2021 May; 50():102843. PubMed ID: 33609924
[TBL] [Abstract][Full Text] [Related]
35. Distinct genetic and infectious profiles in Japanese neuromyelitis optica patients according to anti-aquaporin 4 antibody status.
Yoshimura S; Isobe N; Matsushita T; Yonekawa T; Masaki K; Sato S; Kawano Y; Kira J;
J Neurol Neurosurg Psychiatry; 2013 Jan; 84(1):29-34. PubMed ID: 23038741
[TBL] [Abstract][Full Text] [Related]
36. Evaluating the Economic Burden of Relapses in Neuromyelitis Optica Spectrum Disorder: A Real-World Analysis Using German Claims Data.
Knapp RK; Hardtstock F; Wilke T; Maywald U; Deiters B; Schneider S; Mouchet J
Neurol Ther; 2022 Mar; 11(1):247-263. PubMed ID: 34940956
[TBL] [Abstract][Full Text] [Related]
37. Neuromyelitis optica spectrum disorders with antibodies to myelin oligodendrocyte glycoprotein or aquaporin-4: Clinical and paraclinical characteristics in Algerian patients.
Bouzar M; Daoudi S; Hattab S; Bouzar AA; Deiva K; Wildemann B; Reindl M; Jarius S
J Neurol Sci; 2017 Oct; 381():240-244. PubMed ID: 28991690
[TBL] [Abstract][Full Text] [Related]
38. Prevalence of neuromyelitis optica spectrum disorder and phenotype distribution.
Bizzoco E; Lolli F; Repice AM; Hakiki B; Falcini M; Barilaro A; Taiuti R; Siracusa G; Amato MP; Biagioli T; Lori S; Moretti M; Vinattieri A; Nencini P; Massacesi L; Matà S
J Neurol; 2009 Nov; 256(11):1891-8. PubMed ID: 19479168
[TBL] [Abstract][Full Text] [Related]
39. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome.
Jarius S; Ruprecht K; Kleiter I; Borisow N; Asgari N; Pitarokoili K; Pache F; Stich O; Beume LA; Hümmert MW; Ringelstein M; Trebst C; Winkelmann A; Schwarz A; Buttmann M; Zimmermann H; Kuchling J; Franciotta D; Capobianco M; Siebert E; Lukas C; Korporal-Kuhnke M; Haas J; Fechner K; Brandt AU; Schanda K; Aktas O; Paul F; Reindl M; Wildemann B;
J Neuroinflammation; 2016 Sep; 13(1):280. PubMed ID: 27793206
[TBL] [Abstract][Full Text] [Related]
40. Patient perspectives on neuromyelitis optica spectrum disorders: Data from the PatientsLikeMe online community.
Eaneff S; Wang V; Hanger M; Levy M; Mealy MA; Brandt AU; Eek D; Ratchford JN; Nyberg F; Goodall J; Wicks P
Mult Scler Relat Disord; 2017 Oct; 17():116-122. PubMed ID: 29055439
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
